Pharmaceuticals agency Cipla Ltd on Friday posted a 44.9 per cent bounce in its consolidated revenue after tax (PAT) to Rs 1,155.37 crore within the September 2023 quarter. Its consolidated complete income from the sale of merchandise throughout July-September 2023 rose 14.41 per cent to Rs 6,589.22 crore, in contrast with Rs 5,759.28 crore a yr in the past.
Cipla had posted a consolidated PAT of Rs 797.41 crore within the corresponding quarter final yr, in accordance to a regulatory submitting.
Its complete bills within the September quarter have been 8.43 per cent larger at Rs 5,260.24 crore as in contrast to Rs 4,851.13 crore within the corresponding interval final fiscal, the corporate mentioned.
Total earnings of Cipla within the September quarter was at Rs 6,854.47 crore, up 15.17 per cent. During the quarter, its income from prescription drugs was at Rs 6,452.54 crore, and from new ventures at Rs 263.77 crore.
Shares of Cipla Ltd have been buying and selling at Rs 1,179.70 on BSE on Friday, up 2.57 per cent from the earlier shut.
